Complete Case Presentation Script (A–Z) Good morning doctor. I would like to present my case. My patient is Mr. X, a 56-year-old gentleman who presented to the clinic for asthma follow-up with occasional wheezing and shortness of breath for 2 days. History of Present Illness Patient is a known case of bronchial asthma, Type 2 Diabetes Mellitus, hypertension and dyslipidemia for the past 10 years and is on regular follow-up at Kementerian Kesihatan Malaysia Klinik Kesihatan every 3 months. He came today for asthma follow-up and complained of occasional wheezing and intermittent shortness of breath for the past 2 days. The shortness of breath was gradual in onset, intermittent in nature and associated with wheezing. Symptoms worsen during night time and with dust exposure. There was no fever, cough, sputum production, hemoptysis or chest pain. No symptoms suggestive of upper respiratory tract infection. Patient uses inhaler regularly and claimed compliance to medications. There was no history of ICU admission or intubation due to asthma. There were also no symptoms suggestive of diabetic complications such as polyuria, polydipsia, blurring of vision, numbness of feet or non-healing ulcers. Patient claimed blood pressure and blood sugar were controlled during previous follow-up. --- Systemic Enquiry General System No fever, loss of weight or loss of appetite Respiratory System Occasional wheezing and shortness of breath present No cough, sputum or hemoptysis Cardiovascular System No chest pain, palpitations, orthopnea or PND Endocrine System No polyuria, polydipsia or polyphagia Neurological System No headache, dizziness or weakness of limbs Peripheral Vascular / Diabetic Complication Screening No blurring of vision No numbness of feet No non-healing ulcers Genitourinary System No dysuria or reduced urine output --- Past Medical and Surgical History Bronchial asthma for 10 years Hypertension for 10 years Diabetes Mellitus for 10 years Dyslipidemia for 10 years No previous surgery No history of tuberculosis --- Drug History Currently patient is taking: Metformin Amlodipine Atorvastatin Salbutamol inhaler Patient claimed compliance to medications. No known drug allergy. --- Family History No family history of asthma or other chronic respiratory disease. No family history of premature cardiovascular disease. --- Social History Patient is independent in daily activities. No smoking or alcohol history. Avoidance of dust exposure was advised. --- General Physical Examination Patient was conscious, alert and comfortable at rest. Patient was not tachypneic and not in respiratory distress. No cyanosis, pallor, jaundice or clubbing. No pedal edema. Hydration status was adequate. Vital Signs Blood pressure: 130/80 mmHg Pulse rate: 84 beats per minute, regular Respiratory rate: 20 breaths per minute Temperature: afebrile Oxygen saturation: 98% on room air --- Respiratory Examination On inspection, chest was symmetrical with no deformity. Trachea was centrally located. Chest expansion was equal bilaterally. On auscultation, mild bilateral wheezing was heard. No crepitations were noted. --- Cardiovascular Examination Pulse was regular with good volume. Heart sounds S1 and S2 were normal. No murmur was heard. --- Neurological Examination Patient was conscious and oriented. No focal neurological deficit. --- Diabetic Foot Examination No ulcer or deformity noted. Peripheral pulses were palpable. Sensation was intact. --- Summary This is a 56-year-old gentleman who is a known case of bronchial asthma, Type 2 Diabetes Mellitus, hypertension and dyslipidemia for the past 10 years on regular follow-up at primary care clinic, who presented with intermittent wheezing and shortness of breath for 2 days, worsened by dust exposure and at night. There were no symptoms suggestive of infection or acute severe asthma. Examination revealed mild bilateral wheezing without respiratory distress. --- Provisional / Definitive Diagnosis 1. Partially controlled bronchial asthma on follow-up 2. Type 2 Diabetes Mellitus under follow-up 3. Hypertension under follow-up 4. Dyslipidemia under follow-up --- Investigations Investigations done and planned include: PEFR Pulse oximetry DTX/HbA1c Lipid profile Renal function test Urine microalbumin ECG Blood pressure monitoring --- Management Plan Continue asthma inhalers Continue antihypertensive medications Continue diabetic medications Continue statin therapy Advise avoidance of asthma triggers Lifestyle modification including diet and exercise Education on inhaler technique and medication compliance Regular follow-up at Klinik Kesihatan every 3 to 6 months give me a proper provisional and definitve diagnosis for this case..im not happy with the answer i have uploaded

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Searching the Web

GINA 2024 asthma symptom control classification well controlled partially uncontrolled criteria

Now I have everything I need. Let me put together a proper, well-structured provisional and definitive diagnosis.

Provisional and Definitive Diagnoses

Here is the corrected and properly structured diagnosis section for this case, based on GINA 2024 criteria and primary care context:

Provisional Diagnosis

1. Partly controlled bronchial asthma
This is based on the GINA 2024 symptom control classification. Over the past 4 weeks, the patient scores on 1-2 of the 4 GINA criteria, which defines "partly controlled":
GINA Criterion (past 4 weeks)This Patient
Daytime symptoms >2 days/weekNot clearly stated - occasional
Night waking due to asthmaYes - symptoms worsen at night
SABA reliever needed >2 days/weekNot clearly stated
Any activity limitation due to asthmaNeeds clarification
The key features placing him in "partly controlled" rather than "well controlled" are: nocturnal worsening of symptoms and the fact that he is actively symptomatic (wheezing + dyspnoea for 2 days). He does NOT meet "uncontrolled" (3-4 criteria), and there are no features of acute severe asthma (no tachypnoea, SpO2 98%, no respiratory distress).
Note: Your original phrasing "partially controlled bronchial asthma on follow-up" is not wrong, but it is incomplete and vague. A proper diagnosis should state the reason for the current classification.

Definitive / Working Diagnoses

#DiagnosisBasis
1Partly controlled bronchial asthma (GINA 2024 - 1 to 2 criteria met)Nocturnal worsening, bilateral wheeze on auscultation, triggered by dust, known asthmatic on regular salbutamol inhaler
2Type 2 Diabetes Mellitus, adequately controlledKnown diagnosis for 10 years, no hyperglycaemic symptoms, patient reports controlled blood sugar at last visit; on Metformin
3Essential hypertension, controlledKnown for 10 years, BP today 130/80 mmHg (at target for a diabetic patient per JNC/AHA); on Amlodipine
4Dyslipidaemia, on treatmentKnown diagnosis, on Atorvastatin, no acute features; follow-up lipid profile warranted

Why Your Original Diagnosis Was Incomplete

Your original answer ("partially controlled bronchial asthma on follow-up") had three gaps:
  1. No GINA grading rationale - GINA 2024 classifies asthma symptom control as well controlled, partly controlled, or uncontrolled based on 4 specific criteria in the past 4 weeks. Your diagnosis should name which category and briefly anchor it to the clinical evidence.
  2. No qualifier for the comorbidities - "under follow-up" is not a clinical status. You should state whether each comorbidity is controlled, uncontrolled, or on treatment - this shows clinical reasoning and is expected in both clinical exams and documentation.
  3. No mention of asthma trigger - Dust-induced, nocturnal worsening in a known asthmatic is clinically meaningful and should be reflected in the diagnosis or at minimum in the management plan (which you did include separately - good).

Suggested Write-Up Format

1. Partly controlled bronchial asthma - Triggered by dust exposure, with nocturnal worsening; no features of acute severe asthma. (GINA 2024: 1-2 criteria met)
2. Type 2 Diabetes Mellitus - Adequately controlled on Metformin; no evidence of microvascular or macrovascular complications.
3. Essential hypertension - Controlled; BP 130/80 mmHg today; on Amlodipine.
4. Dyslipidaemia - On Atorvastatin; lipid profile to be reviewed.

One Important Note on Drug History

The patient is on salbutamol inhaler only (a SABA reliever). There is no inhaled corticosteroid (ICS) documented. GINA 2024 recommends that even mild persistent asthma should have a low-dose ICS (or ICS-formoterol as anti-inflammatory reliever). This is a significant management gap worth raising - asthma that is "partly controlled" on SABA alone may warrant a step-up to ICS, or at minimum, confirming whether an ICS was omitted from the drug history.
This is a shared conversation. Sign in to Orris to start your own chat.